Boomer Esiason and Gunnar's Fight Against Cystic Fibrosis

In 1993, NFL quarterback Boomer Esiason received life-altering news when his two-year-old son, Gunnar, was diagnosed with cystic fibrosis (CF), a genetic disorder that leads to severe lung damage and other health complications. Esiason, who was then playing for the New York Jets, was informed of Gunnar's condition during a practice session, prompting him to reach out to his father and sportswriter Frank Deford, a prominent advocate for CF awareness following the death of his daughter from the disease. Deford encouraged Esiason to leverage his platform to raise awareness and funds for CF research, leading to the establishment of the Boomer Esiason Foundation.

CNBC

The Boomer Esiason Foundation has become a significant player in the CF community, providing funding for research, hardship assistance for affected families, and scholarships for students with CF. Esiason's advocacy efforts brought national attention to the challenges faced by those living with CF, culminating in a feature on the cover of Sports Illustrated. Gunnar Esiason, who has been vocal about his experiences, described the rigorous daily care required for managing CF, including the use of a nebulizer and a mechanical vest to clear mucus from his lungs.

CNBC

Gunnar's journey with CF has been fraught with health crises, leading him to feel overwhelmed and trapped in a cycle of treatment. At 22, he found himself back at home, grappling with the limitations imposed by his condition. In 2018, he participated in a clinical trial for Trikafta, a drug developed by Vertex Pharmaceuticals and funded by the Boomer Esiason Foundation. This trial represented a pivotal moment for Gunnar, as he sought not only to improve his own health but also to contribute to the broader CF community. The drug was granted fast track review by the FDA and received approval in 2019.

CNBC

Gunnar emphasized the importance of patient involvement in drug development, stating, "Patients are a finite resource, and the drug development industry does not move forward without them." His participation in the clinical trial was not just a personal endeavor; it was a commitment to advancing treatment options for others with CF. He expressed gratitude for the opportunity to contribute to research that could benefit the entire CF community.

CNBC

• "I had never heard of the disease, and he spoke, and there wasn't a dry eye in the house." — Boomer Esiason

CNBC

• "I was dealing with pulmonary exacerbation after pulmonary exacerbation." — Gunnar Esiason

CNBC

• "When I was offered the opportunity to be involved in the clinical trial, the answer was very quickly yes." — Gunnar Esiason

CNBC

The Esiason family's journey highlights the critical intersection of personal experience and advocacy in the fight against cystic fibrosis. Through the Boomer Esiason Foundation and Gunnar's participation in clinical trials, they continue to raise awareness and push for advancements in treatment, embodying a relentless pursuit of hope for those affected by this challenging disease.

CNBC